Skip to main contentSkip to navigation
Sirius Investors

Nutex Health, Inc. (NUTX) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Nutex Health, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2025
P/E Ratio
14.79
Strong
WeakModerateStrong
P/B Ratio
3.18
Strong
WeakModerateStrong
Earnings Yield
6.76%
Strong
WeakModerateStrong

Profitability Health

2025
Return on Equity
21.49%
Strong
WeakModerateStrong
Operating Margin
31.49%
Strong
WeakModerateStrong
Net Profit Margin
8.09%
Moderate
WeakModerateStrong

Growth Indicators

2025
Revenue Growth
82.36%
Strong
WeakModerateStrong
Net Income Growth
35.67%
Strong
WeakModerateStrong
EPS Growth
8.80%
Moderate
WeakModerateStrong

Efficiency & Liquidity

2025
Current Ratio
3.41
Strong
WeakModerateStrong
Quick Ratio
3.39
Strong
WeakModerateStrong
Asset Turnover
0.95x
Moderate
WeakModerateStrong
Inventory Turnover
150.38x
Strong
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2025
Free Cash Flow Yield
23.45%
Strong
WeakModerateStrong
EV / Free Cash Flow
4.94x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.58x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.888
Moderate
WeakModerateStrong
Return on Invested Capital
25.91%
Strong
WeakModerateStrong
Cash Conversion Cycle
96.66 days
Weak
WeakModerateStrong

Fortress screener guardrails

3/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for NUTX.

View Financial Statements